Company intelligence / Profile preview

SecuGen

Madrid, Madrid, Spain
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Secugen is a Spanish biotechnology company specializing in molecular genetics and DNA sequencing services, now operating as part of the ARQUIMEA group. Founded as a spin-off from the Spanish National Research Council (CSIC), the company provides a comprehensive suite of genomic services, including Sanger sequencing, Next-Generation Sequencing (NGS), and fragment analysis. Secugen also offers specialized genetic diagnostic services for hereditary diseases and rare conditions, catering to clinical, academic, and pharmaceutical sectors. With over three decades of experience, the company is a leading provider of molecular biology solutions in Spain. Their facilities are located within the Centro de Investigaciones Biológicas (CIB-CSIC) in Madrid, facilitating close collaboration with top-tier research institutions.

Therapeutic areas
Rare Diseases
Industry
Molecular Diagnostics
02

Partnerships

CSIC (Spanish National Research Council)Centro de Investigaciones Biológicas (CIB)

Beyond the preview

Go deeper on SecuGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SecuGen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call